Abstract
To determine the prevalence and associated risk factors of diabetic peripheral neuropathy (DPN) among newly diagnosed diabetes mellitus patients in Mulago Hospital. A cross-sectional study was conducted among 248 newly diagnosed adult diabetic patients. Using the standard Neuropathy Symptom Score (NSS) and Neuropathy Disability Score (NDS) criteria, we screened them for neuropathy. Data on the socio-demographics, age, duration of symptoms and history of diabetic ulcer were analyzed using a multiple logistic regression. A p-value <0.05 was considered significant. The majority of study patients (62.1%) were male. The overall prevalence of DPN was 29.4 %. Nearly sixteen percent had moderate neuropathy and only five percent had severe neuropathy. Age above 60 years was significantly associated with the presence of DPN; (OR 3.72; 95% CI 1.25 - 11.03; p=0.018). The history of ever having a foot ulcer was significantly associated with peripheral neuropathy (OR 2.59; 95% CI: 1.03 - 6.49, p = 0.042). DPN occurs in 1 in 4 of newly diagnosed diabetic patients in Mulago hospital. Two thirds of these patients had moderate to severe neuropathy. DPN was independently associated with increasing age. Early diagnosis of diabetes mellitus, increased diabetes knowledge and regular blood sugar screenings would play an important role in identifying this problem.
Highlights
The International Diabetes Federation (IDF) estimates that 19.8 million people have diabetes in Africa where approximately 75% are still undiagnosed[1]
Peripheral neuropathy remains a challenge among diabetic patients and early institution of hypoglycemic agents may slow its progression
Prevalence of diabetic peripheral neuropathy The overall prevalence of DPN among newly diagnosed diabetic patients was 29.4 %. This is the first study to assess the severity and factors associated with peripheral neuropathy in Uganda among newly diagnosed diabetics, earlier studies have described peripheral neuropathy among patients’ attending the out-patient clinics and receiving hypoglycemic agents
Summary
The International Diabetes Federation (IDF) estimates that 19.8 million people have diabetes in Africa where approximately 75% are still undiagnosed[1]. With the incidence of diabetes on the rise, the incidence of diabetic complications like peripheral neuropathy is expected to increase correspondingly[2]. 50 percent of patients with diabetes are estimated to develop neu-
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.